Indeed, the difference in survival is related to the time frame between 15 and 25 days after tumor induction, a periode after anti-PD-L1 or isotype Ctrl treatment and during the tumor elimination phase with GCV therapy. The gene discussed is CD274; the disease is neoplasm.